Skip to main content

Table 1 Association of ASMTL-AS1 expression with clinical features in 68 triple-negative breast cancer patients

From: A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple‐negative breast cancer

Parameters

Total (n = 68)

ASMTL-AS1 expression

P value

Low (n = 34)

High (n = 34)

Age (years)

 ≤ 40

21

9

12

0.431

 > 40

47

25

22

Menopause

 Yes

28

12

16

0.324

 No

40

22

18

Tumor size (cm)

 ≤ 2

32

8

23

<0.001

 > 2

36

25

11

Lymph node metastasis

 Negative

25

7

18

0.006

 Positive

43

27

16

TNM stage

 I-II

23

2

21

<0.001

 III

45

32

13